Offer - Urjas Oil for just ₹ 1 X
Paracristine is a prescription medicine that is available as a Injection. Blood Cancer are some of its major therapeutic uses. Paracristine also has some secondary and off-label uses. These are listed below.
The correct dosage of Paracristine depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
Common side effects of Paracristine include Constipation, Blurred vision, Difficulty walking. Apart from the aforementioned side effects, Paracristine can also lead to other problems, which have been listed below. Usually, these side effects of Paracristine go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Paracristine has a Severe effect for pregnant women and Severe effect on lactating mothers. Warnings related to Paracristine's effects on the liver, heart and kidney, if any, have been listed below.
Other conditions have been mentioned below in the Paracristine contraindications section.
Drug reaction of Paracristine with other medicines has been reported. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Paracristine is not safe while driving, and is is not addictive in nature.
Paracristine is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Paracristine safe for pregnant women?
Paracristine shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Paracristine safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Paracristine. It should only be taken after medical advice.
What is the effect of Paracristine on the Kidneys?
Paracristine rarely harms the kidneys.
What is the effect of Paracristine on the Liver?
The liver can be affected by Paracristine. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Paracristine only after medical advice.
What is the effect of Paracristine on the Heart?
Paracristine is not harmful for the heart.
Paracristine should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
If you are suffering from any of the following diseases, you should not take Paracristine unless your doctor advises you to do so -
Is this Paracristine habit forming or addictive?
Paracristine does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Paracristine can make you feel drowsy.
Is it safe?
Yes, but consume Paracristine only on doctor's advice.
Is it able to treat mental disorders?
No, Paracristine is not used to treat mental disorders.
Interaction between Food and Paracristine
You can take Paracristine with food.
Interaction between Alcohol and Paracristine
No research has been done on this till date. Therefore, it is not known what the effect of taking Paracristine with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vincristine Sulfate
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 865
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1269-1271